U.S. Stock News

NasdaqGS:ZM
NasdaqGS:ZMSoftware

Zoom (ZM) Stock Looks Close To Fair Value Today

Zoom Communications stock has rebounded strongly in the shorter term, yet after a 5 year decline of about 68.5% and a current reading that looks roughly in line with its Discounted Cash Flow (DCF) intrinsic value estimate, the question is whether the recent strength has already used up most of the upside. Over 5 years, the share price is down about 68.5%, which puts the current recovery in the context of a long period of weaker returns for Zoom Communications investors. Expectations around...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Why Is Broadcom (AVGO) Drawing New Scrutiny Over Hidden AI Debt Risks?

Broadcom (NasdaqGS: AVGO) is facing rising investor concern over large off balance sheet AI financing commitments tied to its chip customers. Analysts highlight that Broadcom has taken on substantial obligations to backstop customer leases for its AI chips, creating significant contingent liabilities. Commentary points to the possibility of as much as $370b in senior debt accumulating by mid 2029, drawing fresh scrutiny from bond markets. These hidden debt risks are drawing wider attention...
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

OPKO Health (OPK) Raises $125 Million, Is The Upside Already Priced In?

OPKO Health (OPK) recently expanded its financing relationship with HealthCare Royalty by issuing an additional $125 million in senior secured notes tied to mazdutide royalties from Eli Lilly. This royalty backed deal provided OPKO with immediate, non dilutive capital. See our latest analysis for OPKO Health. The new financing comes after a period where OPKO Health’s 30 day share price return of 15.97% and 90 day share price return of 22.12% contrast with a 5 year total shareholder return...
NYSE:BROS
NYSE:BROSHospitality

Did Dutch Bros' (BROS) Earnings Beat and Real Estate Push Just Redefine Its Growth Narrative?

Dutch Bros Inc. reported past second-quarter 2026 results showing higher sales of US$510.03 million and revenue of US$550.85 million, with net income rising to US$37.41 million and earnings per share improving versus a year earlier, while also lifting its full-year 2026 revenue outlook to between US$2.1 billion and US$2.13 billion. Alongside the earnings beat and upgraded guidance, Dutch Bros moved to accelerate its footprint by agreeing to acquire the real estate of up to 65 Salad and Go...
NYSE:VSH
NYSE:VSHElectronic

Should Vishay Intertechnology’s (VSH) Strong Q2, New Components, and Reseller Deal Prompt Investor Moves?

In recent days, Vishay Intertechnology reported second-quarter 2026 results showing higher sales and earnings year over year, issued third-quarter revenue and margin guidance, introduced new safety capacitors and IR receiver modules, and its partner Flip Electronics, LLC announced an authorized value-added reseller agreement to distribute Vishay’s end-of-life and obsolete discrete semiconductors across multiple end markets. Taken together, these developments highlight how Vishay is pairing...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (CAMT) Is Up 6.5% After Guiding to Strong Q3 Revenue Jump Despite Softer EPS - Has The Bull Case Changed?

In August 2026, Camtek Ltd. reported second-quarter 2026 results showing sales of US$133.24 million, up from US$123.32 million a year earlier, while net income and earnings per share from continuing operations declined year-on-year. At the same time, management issued third-quarter 2026 revenue guidance of US$158 million to US$160 million, implying an exceptional 20% sequential increase that contrasts sharply with the recent earnings pressure. With management now guiding to a sharp...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Intuitive Machines (LUNR) Following Earnings And Defense Win Is The Growth Story Already Priced In

Intuitive Machines (LUNR) just delivered a busy August for investors, combining record second quarter revenue, a larger contract backlog, and a fresh defense win that collectively sharpen the focus on its growth plans. See our latest analysis for Intuitive Machines. The recent earnings release and defense contract news arrived alongside sharp share price swings. Intuitive Machines posted a 40.61% 1 month share price return, but the 90 day share price return is down 43.41%. Meanwhile, the 1...
NYSE:IONQ
NYSE:IONQSemiconductor

How Investors May Respond To IonQ (IONQ) DARPA Clock Win And Higher 2026 Revenue Guidance

In early August 2026, IonQ reported its strongest quarter to date with second-quarter sales rising to US$80.05 million, updated full-year 2026 revenue guidance to US$280 million–US$290 million, and secured a US$28 million DARPA contract extension to scale production of 125 Evergreen-05 optical atomic clocks for U.S. government use. Alongside partnerships with Sandia National Laboratories and EPB’s Tennessee Quantum Communications Research Center, IonQ is committing over US$30 million to new...
BATS:CBOE
BATS:CBOECapital Markets

Cboe Global Markets (CBOE) Stock May Be Fully Valued After A 144% Run

Cboe Global Markets stock has delivered a powerful run over the past five years, yet the current valuation checks suggest the shares are priced at a premium rather than standing out as a clear bargain. Cboe Global Markets has returned 144.0% over five years, which sets a high bar for what investors may reasonably expect from here. Recent growth efforts in areas like options, prediction markets and global clearing can support high expectations, while regulatory changes and business reshaping,...
NasdaqGS:MTSI
NasdaqGS:MTSISemiconductor

Does MACOM’s Q3 Profit Surge And Higher Guidance Reshape The Bull Case For MTSI?

In early August 2026, MACOM Technology Solutions Holdings reported third-quarter sales of US$342.24 million and net income of US$100.71 million, sharply higher than a year earlier, alongside significantly improved earnings per share. Over the first nine months of the fiscal year, the company shifted from a net loss to a net profit while also issuing stronger fourth-quarter revenue guidance of US$415 million to US$425 million, highlighting a marked turnaround in financial performance. We'll...
NYSE:WELL
NYSE:WELLHealth Care REITs

Welltower Stock And Other Defensive REITs for Steady Income in a Slowing US Economy

Cooling inflation, softer retail sales and housing strains are pulling markets in two directions, with income investors caught between rate expectations and worries about slower growth. That mix is putting more attention on real estate linked to everyday needs and steady rent checks. This article walks through three U.S. defensive, income focused real estate stocks exposed to these macro shifts and explains why they may deserve a closer look now. The stocks covered below are just a sample of...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Mirum Pharmaceuticals, Inc. reported past earnings for the second quarter and first half of 2026, disclosing a net loss of US$67.23 million for the quarter and a very large six‑month net loss, with basic loss per share from continuing operations rising to US$1.06 for the quarter and US$14.03 for the half year. The sharp widening of losses compared with the prior year highlights how Mirum’s cost base and investment intensity have increased relative to its current revenue scale. We’ll now...
NYSE:WTTR
NYSE:WTTREnergy Services

Select Water Solutions (WTTR) Posted Strong Earnings Growth, Is The Upside Already Priced In?

What the latest earnings say about Select Water Solutions stock Select Water Solutions (WTTR) drew fresh attention after reporting second quarter 2026 earnings on 4 August. The company reported higher year over year sales, revenue, net income and earnings per share across both the quarter and the first half. See our latest analysis for Select Water Solutions. On the price side, Select Water Solutions has seen steady positive momentum, with a 6.65% 90 day share price return and an 88.10% year...
NYSE:TKR
NYSE:TKRMachinery

Timken (TKR) As Q2 Results And Guidance Lift Put Valuation Back In Focus

Timken (TKR) shares are reacting to a busy August update, with second quarter earnings, fresh full year guidance, a new dividend declaration, and progress on its ongoing share repurchase program all landing within days. See our latest analysis for Timken. At the current share price of $133.50, Timken has given investors a strong 90 day share price return of 18.42% and a 1 year total shareholder return of 78.39%, although the 30 day share price return is down 3.11%. This suggests momentum has...
NYSE:IBP
NYSE:IBPConsumer Durables

Installed Building Products (IBP) Beat Second Quarter Estimates, Is The Stock Slightly Overvalued?

Installed Building Products (IBP) is back in focus after second quarter results topped Wall Street expectations, with commercial installations and recent acquisitions helping offset softer single family residential demand, according to management commentary. See our latest analysis for Installed Building Products. Installed Building Products shares have pulled back in the short term, with the 1 day share price return down 2.38% and the year to date share price return down 10.18%. However, the...
NasdaqGS:DMLP
NasdaqGS:DMLPOil and Gas

Dorchester Minerals (DMLP) Could Be 74% Below Fair Value As Earnings Improve

Dorchester Minerals (DMLP) recently reported second quarter 2026 results that showed higher revenue and net income compared with a year earlier. The update gives you fresh information on how this royalty focused partnership is performing. See our latest analysis for Dorchester Minerals. Dorchester Minerals' recent earnings and the Williston Basin acquisition come against a share price of $27.71, with year to date share price return of 19.18% and a five year total shareholder return of...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Should Constellation’s Long-Term Nuclear AI Power Deals and Leadership Shift Require Action From Constellation Energy (CEG) Investors?

In the second quarter of 2026, Constellation Energy reported sales of US$7,504 million and net income of US$513 million, while also declaring a quarterly dividend of US$0.4265 per share payable on September 4, 2026, and announcing board changes including CEO Joseph Dominguez becoming chair. The company’s push into long-term nuclear power agreements with large corporate customers, including an 18.5-year average contract duration across roughly 920 megawatts, highlights its growing role as a...
NYSE:PGR
NYSE:PGRInsurance

Progressive (PGR) Could Be 9% Undervalued As Q2 Earnings Beat Estimates

Progressive (PGR) is back in focus after its second quarter 2026 earnings per share of $4.85 came in 3.2% above consensus, with net premiums written of $21.1b and broader policy growth. See our latest analysis for Progressive. Progressive’s recent earnings beat and ongoing share repurchases have come against a mixed price backdrop, with a modest 90 day share price return of 2.75% but a 1 year total shareholder return that declined 9.68%, while the 5 year total shareholder return of 140.12%...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell International (HON), Why Is It Getting Fresh Attention?

Honeywell International (HON) is in focus after management advanced the spin off of its Aerospace Technologies unit and set new multi year financial targets tied to software, automation, AI and higher growth industrial projects. See our latest analysis for Honeywell International. Honeywell International’s recent announcements come after a mixed share price stretch, with the stock at US$233.96 and a 30 day share price return of 3.97%, while the year to date share price return has fallen...
NYSEAM:HYLN
NYSEAM:HYLNElectrical

US Penny Stocks With Strong Balance Sheets Investors May Be Missing

Higher US inflation expectations and rising Treasury yields are putting pressure on many growth stocks. That can push some investors toward cheaper corners of the market where balance sheets still look sound. The Financially Fit Penny Stocks screener focuses on lower priced stocks with healthier finances, which can matter more when money is not as cheap. This article highlights three such candidates and explains why they may deserve a closer look now. The stocks in the article below are just...
NYSE:CNA
NYSE:CNAInsurance

Will Mixed Q2 Earnings and Steady Dividend Payouts Reshape CNA Financial's (CNA) Narrative?

CNA Financial Corporation recently reported second-quarter 2026 results, with revenue of US$3,829 million and net income of US$321 million, and affirmed a quarterly cash dividend of US$0.48 per share payable on September 3, 2026. An interesting angle is that while second-quarter earnings per share from continuing operations increased year on year, net income for the first half of 2026 was lower than in the same period of 2025, highlighting mixed momentum across timeframes. With recent...
NasdaqCM:XMAX
NasdaqCM:XMAXConsumer Durables

XMax (XMAX) Stock Eyes Earnings Reset After Sharp Profit Swing

XMax shares inched up about 2% into the weekend, yet the real jolt is in the earnings line. The stock barely moved, while Q2 net income and earnings per share swung sharply into profit, marking a clean break from last year’s losses. The key point is straightforward: XMax has shifted from fighting for survival on the income statement to reporting positive EPS, even as the market still prices the stock on a modest P/E next to peers. Is XMax trading at a genuine earnings reset discount, or has...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

Why AbCellera (ABCL) Is Up 64.2% After Menopause Trial Win, Equity Raise And Vertex Deal

In August 2026, AbCellera Biologics Inc. reported positive Phase 2 results for its investigational menopause drug ABCL635 and completed a roughly US$200.00 million follow-on equity offering of common stock and pre-funded warrants. These developments, alongside a new collaboration with Vertex Pharmaceuticals on multispecific T‑cell engagers for autoimmune diseases, highlight AbCellera’s effort to expand its clinical pipeline while strengthening its funding base. We’ll now examine how the...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

UFP Technologies (UFPT) Reported Strong Quarterly Growth, Is The Premium Already Priced In?

UFP Technologies (UFPT) reported second quarter 2026 results that caught investor attention, with sales of US$173.96 million and net income of US$20.85 million, compared with US$151.18 million and US$17.18 million a year earlier. See our latest analysis for UFP Technologies. The earnings release has arrived alongside a sharp shift in sentiment, with UFP Technologies’ share price delivering a 30 day share price return of 32.93% and a year to date share price return of 44.03%. Over a longer...